SESN2 and metabolic dysfunction-associated steatotic liver disease: Here, we aimed to explore the potential mechanism by which EMPA protects against lipogenesis and inflammation through assessment of Sesn2-mediated AMPK-mTOR signaling and cellular antioxidant signaling in a model of high-fat diet (HFD)-induced NAFLD.